EPM
BDSX icon

Equitec Proprietary Markets’s Biodesix BDSX Stock Holding History

Equitec Proprietary Markets’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-345
Closed -$11K – 258
2022
Q2 		$11K Buy
+345
New +$11.2K ﹤0.01% 180

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Equitec Proprietary Markets's BDSX Position: Q3 2022 in Review

Equitec Proprietary Markets sold out of Biodesix (BDSX) in Q3 2022, closing a stake of 345 shares — an estimated $11K sold.

Equitec Proprietary Markets first reported a position in BDSX in Q2 2022 and held it in 1 quarter. The position peaked at $11K in Q2 2022. 27 funds tracked by Wall St. Rank hold BDSX as of Q3 2022.

  • Equitec Proprietary Markets reported no remaining Biodesix position as of Q3 2022 after selling out during the quarter.
  • Equitec Proprietary Markets sold 345 Biodesix shares in Q3 2022, an estimated $11K.
  • Equitec Proprietary Markets first reported a position in Biodesix in Q2 2022 and held it in 1 quarter.
  • Equitec Proprietary Markets's Biodesix position peaked at $11K in Q2 2022.
  • 27 funds tracked by Wall St. Rank held Biodesix as of Q3 2022.

Based on Equitec Proprietary Markets's 13F filing for Q3 2022, filed 11 Oct 2022.